IT1261695B - Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono. - Google Patents

Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.

Info

Publication number
IT1261695B
IT1261695B ITRM930364A ITRM930364A IT1261695B IT 1261695 B IT1261695 B IT 1261695B IT RM930364 A ITRM930364 A IT RM930364A IT RM930364 A ITRM930364 A IT RM930364A IT 1261695 B IT1261695 B IT 1261695B
Authority
IT
Italy
Prior art keywords
carnitine
transfusions
blood
alcanoil
preservation
Prior art date
Application number
ITRM930364A
Other languages
English (en)
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM930364A0 publication Critical patent/ITRM930364A0/it
Priority to ITRM930364A priority Critical patent/IT1261695B/it
Priority to ES94830254T priority patent/ES2122214T3/es
Priority to EP94830254A priority patent/EP0627161B1/en
Priority to DK94830254T priority patent/DK0627161T3/da
Priority to AT94830254T priority patent/ATE170709T1/de
Priority to DE69413120T priority patent/DE69413120T2/de
Priority to JP11993494A priority patent/JP3573791B2/ja
Priority to US08/253,275 priority patent/US5496821A/en
Publication of ITRM930364A1 publication Critical patent/ITRM930364A1/it
Application granted granted Critical
Publication of IT1261695B publication Critical patent/IT1261695B/it
Priority to US09/035,028 priority patent/USRE36331E/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Vengono descritte soluzioni stabilizzatrici per la conservazione del sangue per trasfusioni, comprendenti L-carnitina, alcanoil L-carnitine o loro sali farmacologicamente accettabili.
ITRM930364A 1993-06-02 1993-06-02 Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono. IT1261695B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITRM930364A IT1261695B (it) 1993-06-02 1993-06-02 Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.
AT94830254T ATE170709T1 (de) 1993-06-02 1994-05-26 Verwendung von l-carnitin und alkanoyl l- carnitine zum bewahren von transfusionsblut, und sie enthaltenden stabilisierungslösungen
EP94830254A EP0627161B1 (en) 1993-06-02 1994-05-26 Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them
DK94830254T DK0627161T3 (da) 1993-06-02 1994-05-26 Anvendelse af L-carnitin og alkanoyl L-carnitiner til opbevaring af blod til trandfusioner og stabiliserende opløsninger in
ES94830254T ES2122214T3 (es) 1993-06-02 1994-05-26 Empleo de l-carnitina y alcanoil l-carnitinas en el almacenamiento de sangre para transfusiones y estabilizacion de soluciones que la contienen.
DE69413120T DE69413120T2 (de) 1993-06-02 1994-05-26 Verwendung von L-Carnitin und Alkanoyl L-Carnitine zum Bewahren von Transfusionsblut, und sie enthaltenden Stabilisierungslösungen
JP11993494A JP3573791B2 (ja) 1993-06-02 1994-06-01 Ｌ−カルニチン類を含む輸血用血液保存のための安定化溶液
US08/253,275 US5496821A (en) 1993-06-02 1994-06-02 Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them
US09/035,028 USRE36331E (en) 1993-06-02 1998-03-05 Use of L-carnitine and alkanoyl L-carnitines in the storage of blood for transfusions and stabilizing solutions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930364A IT1261695B (it) 1993-06-02 1993-06-02 Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.

Publications (3)

Publication Number Publication Date
ITRM930364A0 ITRM930364A0 (it) 1993-06-02
ITRM930364A1 ITRM930364A1 (it) 1994-12-02
IT1261695B true IT1261695B (it) 1996-05-29

Family

ID=11401790

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930364A IT1261695B (it) 1993-06-02 1993-06-02 Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.

Country Status (8)

Country Link
US (2) US5496821A (it)
EP (1) EP0627161B1 (it)
JP (1) JP3573791B2 (it)
AT (1) ATE170709T1 (it)
DE (1) DE69413120T2 (it)
DK (1) DK0627161T3 (it)
ES (1) ES2122214T3 (it)
IT (1) IT1261695B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482585B2 (en) * 1997-04-16 2002-11-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
US6403124B1 (en) * 1997-04-16 2002-06-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
ATE316757T1 (de) 1998-05-26 2006-02-15 Lifecell Corp Cryokonservierung menschlicher roter blutzellen
CZ303870B6 (cs) 1999-10-11 2013-06-05 Sigma-Tau Industrie Farmaceutiche Riunite S. P. A. Vyuzití L-karnitinu a jeho alkanoylderivátu jako osmotických prostredku v roztocích pro medicinální vyuzití
GB0001172D0 (en) * 2000-01-20 2000-03-08 Res Del International Limited Physiological medium for perfusing, preserving and storing isolated cell tissue and organ samples
ITRM20010337A1 (it) 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
WO2003097237A2 (en) * 2002-05-13 2003-11-27 Becton, Dickinson, And Company Protease inhibitor sample collection system
CA2501196A1 (en) * 2002-10-10 2004-04-22 Becton, Dickinson And Company Sample collection system with caspase inhibitor
EP1659862A2 (en) * 2003-08-04 2006-05-31 Human Biosystems Preservation of blood cells
US20050124965A1 (en) * 2003-12-08 2005-06-09 Becton, Dickinson And Company Phosphatase inhibitor sample collection system
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040346A1 (it) * 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
WO2011049709A1 (en) 2009-10-23 2011-04-28 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
JP5824950B2 (ja) * 2011-08-08 2015-12-02 ソニー株式会社 血液分析装置および血液分析方法
CN114786481A (zh) * 2019-11-29 2022-07-22 新泽西鲁特格斯州立大学 用于储存血液制品的组合物、试剂盒和方法及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639532A (it) *
DE2532183C3 (de) * 1975-07-18 1982-03-04 Behringwerke Ag, 3550 Marburg Polyionische isotonische Salzlösung zur Konservierung von Erythrozyten oder zur Perfusion und zur Konservierung von zur Transplantion bestimmter Organen
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4731360A (en) * 1985-08-16 1988-03-15 Merck & Co., Inc. Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments
US4839159A (en) * 1988-02-08 1989-06-13 Topicarn, Inc. Topical L-carnitine composition
DE3905312A1 (de) * 1989-02-21 1990-08-23 Bayer Ag Substituierte 3-amino-2-pyrazolin-5-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati

Also Published As

Publication number Publication date
US5496821A (en) 1996-03-05
JP3573791B2 (ja) 2004-10-06
JPH0748329A (ja) 1995-02-21
DE69413120T2 (de) 1999-02-11
ITRM930364A0 (it) 1993-06-02
DE69413120D1 (de) 1998-10-15
DK0627161T3 (da) 1999-06-07
ES2122214T3 (es) 1998-12-16
ITRM930364A1 (it) 1994-12-02
EP0627161A1 (en) 1994-12-07
ATE170709T1 (de) 1998-09-15
USRE36331E (en) 1999-10-05
EP0627161B1 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
IT1261695B (it) Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.
AU692430C (en) Aqueous pharmaceutical preparations of G-CSF with a long shelf life
CA2120303A1 (en) Cyclic adhesion inhibitors
HRP20000494B1 (en) Pharmaceutically active morpholinol
MX9200361A (es) Nuevo uso del antagonista de adenosina.
ATE308999T1 (de) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ES2127558T3 (es) Agentes conservantes.
AR003176A1 (es) Una composicion farmaceutica para inhibir el crecimiento de cancer
ATE260559T1 (de) Sordarinderivate
EP0268135A3 (en) Coccidiocidal agents
ES2111891T3 (es) Empleo de l-carnitina o acil l-carnitinas y valproato para tratar trastornos epilepticos.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
ITRM910085A0 (it) Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
AU1706392A (en) The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
CA2481005A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
YU17002A (sh) Upotreba deksrazoksana u lečenju psorijaze
BG104385A (en) Physiologically acceptable aqueous solutions and methods for their application
ES2051788T3 (es) Un producto farmaceutico.
ES1011276Y (es) Mesa para reconocimientos medicos,tratamientos de belleza y similares.
MX9701031A (es) Utilizacion de la selegilina para el tratamiento de enfermedades epilepticas.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970515